What we're reading, May 27, 2016: treatment for pregnant women is often based on guesswork since few drugs are ever tested on them; a new superbug in the US is resistant to even the antibiotic of last resort; and how small physician practices can adapt to new payment models.
With most drugs never tested on pregnant women, treatment is often based on guesswork. According to a report in ProPublica, the desire to protect the fetus has deterred scientists and drug makers from studying expectant mothers, which means almost every drug prescribed during pregnancy in the US is considered “off label.” However, as many as 9 in 10 pregnant women use medications and yet ob/gyns often find themselves in the dark about basic best practices.
A new superbug has arrived in the United States that is resistant to antibiotics of last resort. The deadly antibiotic-resistant strain, which has already been identified in China, Europe, and elsewhere, could mean the end of antibiotics, according to The Washington Post. Scientists and public health officials warn that if resistant bacteria spread, minor infections could become life threatening, pneumonia could become more difficult to treat, and even routine operations could become deadly.
In a post on The Commonwealth Fund’s website, David Blumenthal, MD, and David Squires consider how small physician practices can adjust to new payment models in healthcare. Reforms such as the Medicare Access and CHIP Reauthorization Act seem to favor larger practices over small or solo practices. However, Blumenthal and Squires outline ways in which small practices can transition to the new payment paradigm, such as improved health information technology and physician networks.
HOPE-CAT Can Identify Maternal Cardiovascular Risk 2 Months Earlier Than Doctors, Study Says
April 25th 2024In a retrospective study, the machine learning tool was able to screen for potential risks of cardiovascular disease nearly 60 days before the patient's medical record showed any signs of a related condition or before they were officially diagnosed or treated for it.
Read More
Downward Morbidity, Mortality Trends Discovered Among Patients With Ovarian Cancer, Liver Metastases
April 24th 2024This study indicates a declining trend in morbidity and mortality rates among patients with ovarian cancer and liver metastases, highlighting the efficacy of surgery and chemotherapy in improving survival outcomes.
Read More
The Federal Trade Commission's (FTC's) vote to ban most employers from issuing and enforcing noncompete clauses could have varying impacts on the health care workforce; federal regulators vastly under-enforced antitrust laws in the hospital sector during the last 2 decades, resulting in increased health costs; the FDA recently found genetic evidence of the H5N1 bird flu virus in pasteurized commercially purchased milk.
Read More